Many ovarian cancer marker molecules, such as CA125, CD44, and HE4, contain Lewis y antigen structure, and Lewis y antigen modifications also enhance the processes mediated by these molecules that promote tumor occurrence and development [8, 11]. This evidence concerns the gene WFDC2 and neoplasm.